Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.mdsabstracts.org/abstract/risk-of-motor-complications-in-early-parkinsons-disease-patients-treated-with-opicapone-in-the-epsilon-study-effect-of-levodopa-dose/
 
J. Ferreira; O. Rascol; F. Stocchi; A. Antonini; H. Brigas; J. Moreira; JF. Rocha; M. Fonseca; D. Ramos; J. Holenz; W. Poewe
 
Oct 16, 2025
 
Prev Next